Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001109 · ClinicalTrials.gov registry record
A Blood Test to Look at Cells of the Immune System in Healthy Children
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 630
- Enrollment target
NCT00001109: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00001109 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 630 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001109 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 630 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about some of the immune cells in the blood (CD4 cells, for example) of healthy children in order to better understand the differences in the blood cells of children infected with HIV. Because children's bodies are still developing, their cells are different from those of adults, and their bodies respond differently to infections such as HIV. In order to understand how immune cells grow and mature so that they can fight HIV, it is important to see how these cells behave in normal children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
What the finished NCT00001109 record still lists
NCT00001109 is an observational study that tracks outcomes without assigning an intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001109 about?
NCT00001109 is a clinical study titled "A Blood Test to Look at Cells of the Immune System in Healthy Children". The purpose of this study is to learn more about some of the immune cells in the blood (CD4 cells, for example) of healthy children in order to better understand the differences in the blood cells of children infected with HIV. Because children's bodies are still developing, their cells are differe...
What is the current status of trial NCT00001109?
This trial is currently completed. The enrollment target is 630 participants.
Who is sponsoring clinical trial NCT00001109?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members